Spiderwort: $3.4M raised by biomaterials startup for scaffolds to treat spinal cord injuries
Biomaterials startup Spiderwort has closed a $3.4 million seed financing round one year after it secured $500,000 in a friends and family funding round, Betakit reports.
Read full article »
Spiderwort is a Canada-based biotechnology company that develops and commercializes novel cellulose biomaterials for the treatment of soft tissue replacement.
Read more